Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
For COVID-19 plus diabetes, glycemic control tops treatment list
Tight glucose control led to better results in patients with diabetes and COVID-19.
Half of type 1 diabetes patients with COVID-19 manage at home
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to...
10% with diabetes hospitalized for COVID-19 die within a week
“Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission...
‘The story unfolding is worrisome’ for diabetes and COVID-19
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ...
Seek safe strategies to diagnose gestational diabetes during pandemic
Glucose control linked to COVID-19 outcomes in largest-yet study
Wuhan researchers found preexisting type 2 diabetes worsened prognosis of COVID-19; but those whose glucose stayed “in-range” had better outcomes...
More guidance on inpatient management of blood glucose in COVID-19
Diabetes UK’s COVID-19 task force addresses inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when IVs are...
FDA approves dapagliflozin for low-EF heart failure